CWBR
Price:
$0.49
Market Cap:
$1.42M
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 ...[Read more]
Industry
Biotechnology
IPO Date
2017-12-15
Stock Exchange
NASDAQ
Ticker
CWBR
According to CohBar, Inc.’s latest financial reports and current stock price. The company's current ROE is -58.44%. This represents a change of 140.17% compared to the average of -24.33% of the last 4 quarters.
The mean historical ROE of CohBar, Inc. over the last ten years is 206.70%. The current -58.44% ROE has changed -128.27% with respect to the historical average. Over the past ten years (40 quarters), CWBR's ROE was at its highest in in the March 2014 quarter at 859.49%. The ROE was at its lowest in in the March 2020 quarter at -74.69%.
Average
206.70%
Median
-78.59%
Minimum
-170.13%
Maximum
2.95%
Discovering the peaks and valleys of CohBar, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.85%
Maximum Annual ROE = 2.95%
Minimum Annual Increase = -1755.43%
Minimum Annual ROE = -170.13%
Year | ROE | Change |
---|---|---|
2022 | -78.02% | 29.67% |
2021 | -60.17% | -23.99% |
2020 | -79.16% | -52.81% |
2019 | -167.75% | 91.85% |
2018 | -87.44% | -32.25% |
2017 | -129.06% | 84.79% |
2016 | -69.84% | 76.71% |
2015 | -39.52% | -76.77% |
2014 | -170.13% | -105.77% |
2013 | 2.95% | -1755.43% |
The current ROE of CohBar, Inc. (CWBR) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-72.45%
5-year avg
-94.51%
10-year avg
206.70%
CohBar, Inc.’s ROE is greater than Enveric Biosciences, Inc. (-234.16%), greater than Elevation Oncology, Inc. (-57.97%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), greater than Zura Bio Limited (-35.45%), less than Ocean Biomedical, Inc. (64.85%), less than AVROBIO, Inc. (29.68%), less than eFFECTOR Therapeutics, Inc. (2.18%),
Company | ROE | Market cap |
---|---|---|
-234.16% | $3.75M | |
-57.97% | $30.29M | |
-328.66% | $3.37M | |
-35.45% | $258.92M | |
64.85% | $31.57M | |
29.68% | $5.24M | |
2.18% | $118.08K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CohBar, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CohBar, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CohBar, Inc.'s ROE?
How is the ROE calculated for CohBar, Inc. (CWBR)?
What is the highest ROE for CohBar, Inc. (CWBR)?
What is the 3-year average ROE for CohBar, Inc. (CWBR)?
What is the 5-year average ROE for CohBar, Inc. (CWBR)?
How does the current ROE for CohBar, Inc. (CWBR) compare to its historical average?